Skip to main content
. 2017 May 5;8(32):52923–52934. doi: 10.18632/oncotarget.17629

Figure 7. Effect of injection of wortmannin on expressions of glial fibrillary acidic protein (GFAP) and nerve growth factor (NGF) detected by immunofluorescence assay.

Figure 7

Note: (A) expressions of GFAP and NGF detected by immunofluorescence assay in the wortmannin-positive control, dimethyl sulfoxide (DMSO) and wortmannin groups, Scale bar = 20 μm (×400); (B) comparison of relative integrated optical density (IOD) values of GFAP and NGF among the wortmannin-positive control, dimethyl sulfoxide (DMSO) and wortmannin groups; *, P< 0.05 in comparison with the wortmannin-positive control group; #, P < 0.05 in comparison with the DMSO group.